Dimethyl Fumarate Ameliorates the Endometriosis Through Anti‐Inflammatory and Anti‐Proliferation Mechanisms In Vitro and In Vivo

In: Advanced Therapeutics · 2024 · vol. 7(11) · doi:10.1002/adtp.202400237 · W4401290616
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Dimethyl fumarate reduces endometriosis lesion growth and inflammation in mice and affects key cellular mechanisms in human endometrial stromal cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Dimethyl fumarate is a widely known therapeutic agent with anti‐inflammatory properties for psoriasis and multiple sclerosis. Despite the current attempts to use dimethyl fumarate for treating various inflammatory diseases, its effects on endometriosis have not been previously reported. Endometriosis is a genital disease that causes various health problems in women, and treatment methods targeting the inflammatory environment are being attempted. Therefore, it is hypothesized that dimethyl fumarate has therapeutic effects on endometriosis through its anti‐inflammatory effects. Dimethyl fumarate exerted remarkable effects on cellular mechanisms, including reactive oxygen species production, activation of mitogen‑activated protein kinase signals, loss of mitochondrial function, and disruption of calcium ion homeostasis in the immortalized human ovarian endometrial stromal cells. In an endometriosis mouse model, dimethyl fumarate downregulated cell cycle‐related genes and induced inhibitory effects on endometriosis lesion growth. In particular, the immune cell population and expression of inflammatory cytokines such as IL‐1β, IL‐6, and IL‐10 are regulated by dimethyl fumarate. These results support its potential as a therapeutic agent to control the excessive inflammatory environment in patients with endometriosis. This study identifies for the first time that dimethyl fumarate, which is already in clinical use, can be used to treat endometriosis.
Full text 13,333 characters · extracted from oa-doi-fallback · click to expand
Advanced Hub Main Navigation Menu Dimethyl Fumarate Ameliorates the Endometriosis Through Anti-Inflammatory and Anti-Proliferation Mechanisms In Vitro and In Vivo Miji Kim Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841 Republic of Korea Search for more papers by this authorWonhyoung Park Department of Animal Science, Chungbuk National University, Cheongju, 28644 Republic of Korea Search for more papers by this authorHee Seung Kim Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, 03080 Republic of Korea Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, 03080 Republic of Korea Search for more papers by this authorSoo Jin Park Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, 03080 Republic of Korea Search for more papers by this authorWhasun Lim Department of Biological Sciences, College of Science, Sungkyunkwan University, Suwon, 16419 Republic of Korea Search for more papers by this authorCorresponding Author Gwonhwa Song Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841 Republic of Korea E-mail: [email protected]; [email protected] Search for more papers by this authorCorresponding Author Sunwoo Park Department of GreenBio Science, Gyeongsang National University, Jinju, 52725 Republic of Korea E-mail: [email protected]; [email protected] Search for more papers by this authorMiji Kim Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841 Republic of Korea Search for more papers by this authorWonhyoung Park Department of Animal Science, Chungbuk National University, Cheongju, 28644 Republic of Korea Search for more papers by this authorHee Seung Kim Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, 03080 Republic of Korea Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, 03080 Republic of Korea Search for more papers by this authorSoo Jin Park Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, 03080 Republic of Korea Search for more papers by this authorWhasun Lim Department of Biological Sciences, College of Science, Sungkyunkwan University, Suwon, 16419 Republic of Korea Search for more papers by this authorCorresponding Author Gwonhwa Song Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841 Republic of Korea E-mail: [email protected]; [email protected] Search for more papers by this authorCorresponding Author Sunwoo Park Department of GreenBio Science, Gyeongsang National University, Jinju, 52725 Republic of Korea E-mail: [email protected]; [email protected] Search for more papers by this authorAbstract Dimethyl fumarate is a widely known therapeutic agent with anti-inflammatory properties for psoriasis and multiple sclerosis. Despite the current attempts to use dimethyl fumarate for treating various inflammatory diseases, its effects on endometriosis have not been previously reported. Endometriosis is a genital disease that causes various health problems in women, and treatment methods targeting the inflammatory environment are being attempted. Therefore, it is hypothesized that dimethyl fumarate has therapeutic effects on endometriosis through its anti-inflammatory effects. Dimethyl fumarate exerted remarkable effects on cellular mechanisms, including reactive oxygen species production, activation of mitogen‑activated protein kinase signals, loss of mitochondrial function, and disruption of calcium ion homeostasis in the immortalized human ovarian endometrial stromal cells. In an endometriosis mouse model, dimethyl fumarate downregulated cell cycle-related genes and induced inhibitory effects on endometriosis lesion growth. In particular, the immune cell population and expression of inflammatory cytokines such as IL-1β, IL-6, and IL-10 are regulated by dimethyl fumarate. These results support its potential as a therapeutic agent to control the excessive inflammatory environment in patients with endometriosis. This study identifies for the first time that dimethyl fumarate, which is already in clinical use, can be used to treat endometriosis. Conflict of Interest The authors declare no conflict of interest. Data Availability Statement Data sharing is not applicable to this article as no new data were created or analyzed in this study. References - 1L. C. Giudice, L. C. Kao, Endometriosis. Lancet 2004, 364, 1789. - 2E. S. Surrey, A. M. Soliman, B. Johns, J. B. Vora, H. S. Taylor, S. K. Agarwal, Clinicoecon. Outcomes Res. 2020, 12, 473. - 3I. Selcuk, G. Bozdag, J. Turk. Ger. Gynecol. Assoc. 2013, 14, 98. - 4C. J. Lee, M. J. Kang, S. Y. Kim, I. H. Han, H. S. Bae, Mol. Cell. Toxicol. 2022, 18, 111. - 5S. H. Ahn, K. Khalaj, S. L. Young, B. A. Lessey, M. Koti, C. Tayade, Fertil. Steril. 2016, 106, 1420. - 6L. K. Symons, J. E. Miller, V. R. Kay, R. M. Marks, K. Liblik, M. Koti, C. Tayade, Trends Mol. Med. 2018, 24, 748. - 7J. Donnez, L. Cacciottola, Int. J. Mol. Sci. 2022, 23, 1518. - 8R. Villanacci, V. Bandini, J. Ottolina, L. Pagliardini, M. Candiani, P. Viganò, Minerva. Obstet. Gynecol. 2021, 73, 275. - 9L. Kappos, R. Gold, D. H. Miller, D. G. MacManus, E. Havrdova, V. Limmroth, C. H. Polman, K. Schmierer, T. A. Yousry, M. Yang, M. Eraksoy, E. Meluzinova, I. Rektor, K. T. Dawson, A. W. Sandrock, G. N. O'Neill, Lancet 2008, 372, 1463. - 10R. Reszke, J. C. Szepietowski, Expert. Opin. Drug Saf. 2020, 19, 373. - 11Z. Al-Jaderi, A. A. Maghazachi, Front. Immunol. 2016, 7, 278. - 12L. Prosperini, S. Pontecorvo, Ther. Clin. Risk Manag. 2016, 12, 339. - 13S. Kourakis, C. Timpani, J. Haan, N. Gueven, D. Fischer, E. Rybalka, Pharmaceuticals (Basel) 2020, 13. - 14D. Son, H. Park, G. An, S. Park, D. W. Hwang, S. J. Park, H. S. Kim, W. Lim, S. You, G. Song, Reprod. Sci. 2023, 30, 2703. - 15J. L. Yovich, P. K. Rowlands, S. Lingham, M. Sillender, S. Srinivasan, Reprod. Biomed. Online 2020, 40, 7. - 16I. Lakshmanan, S. K. Batra, Bio. Protoc. 2013, 3, e374. - 17J. Checa, J. M. Aran, J. Inflamm. Res. 2020, 13, 1057. - 18W. Che, M. Manetsch, T. Quante, Md. M Rahman, B. S. Patel, Q. Ge, A. J. Ammit, Biochim. Biophys. Acta 2012, 1823, 1658. - 19D. Vargas-Ibarra, M. Velez-Vasquez, M. Bermudez-Munoz, in Post-Translational Modifications in Cellular Functions and Diseases, IntechOpen, UNITED KINGDOM 2021. 10.5772/intechopen.97061Google Scholar - 20L. Yuan, J. Wang, H. Xiao, W. Wu, Y. Wang, X. Liu, Food Chem. Toxicol. 2013, 53, 62. - 21D. B. Zorov, M. Juhaszova, S. J. Sollott, Physiol. Rev. 2014, 94, 909. - 22J. L. Herington, K. L. Bruner-Tran, J. A. Lucas, K. G. Osteen, Expert Rev. Clin. Immunol. 2011, 7, 611. - 23M. Abramiuk, E. Grywalska, P. Malkowska, O. Sierawska, R. Hrynkiewicz, P. Niedzwiedzka-Rystwej, Cells 2022, 11. - 24J. M. Zhang, J. An, Int. Anesthesiol. Clin. 2007, 45, 27. - 25A. J. Gill, D. L. Kolson, Crit. Rev. Immunol. 2013, 33, 307. - 26R. A. Linker, D.-H. Lee, S. Ryan, A. M. van Dam, R. Conrad, P. Bista, W. Zeng, X. Hronowsky, A. Buko, S. Chollate, G. Ellrichmann, W. Brück, K. Dawson, S. Goelz, S. Wiese, R. H. Scannevin, M. Lukashev, R. Gold, Brain 2011, 134, 678. - 27X. Xie, Y. Zhao, C.-Y. Ma, X.-M. Xu, Y.-Q. Zhang, C.-G. Wang, J. Jin, X. Shen, J.-L. Gao, N. Li, Z.-J. Sun, D.-L. Dong, Br. J. Pharmacol. 2015, 172, 3929. - 28J. A. McCubrey, M. M. Lahair, R. A. Franklin, Antioxid. Redox. Signal 2006, 8, 1775. - 29F. Taniguchi, A. Kaponis, M. Izawa, T. Kiyama, I. Deura, M. Ito, T. Iwabe, G. Adonakis, N. Terakawa, T. Harada, Front. Biosci. 2011, 3, 648. 10.2741/e277Google Scholar - 30S. Cagnol, J. C. Chambard, FEBS J. 2010, 277, 2. - 31C. W. Kang, M. Park, H. J. Lee, Mol. Cell. Toxicol. 2023, 20, 679. 10.1007/s13273-023-00401-xGoogle Scholar - 32A. Aminzadeh, A. R. Dehpour, M. Safa, S. Mirzamohammadi, A. M. Sharifi, Cell. Mol. Neurobiol. 2014, 34, 1143. - 33B. J. Kim, S. W. Ryu, B. J. Song, J. Biol. Chem. 2006, 281, 21256. - 34C. Giorgi, A. Romagnoli, P. Pinton, R. Rizzuto, Curr. Mol. Med. 2008, 8, 119. - 35M. H. Kim, S. Park, G. Song, W. Lim, Y. S. Han, Mol. Cell. Toxicol. 2022, 18, 383. - 36O. H. Petersen, J. V. Gerasimenko, O. V. Gerasimenko, O. Gryshchenko, S. Peng, Physiol. Rev. 2021, 101, 1691. - 37C. Giorgi, F. Baldassari, A. Bononi, M. Bonora, E. De Marchi, S. Marchi, S. Missiroli, S. Patergnani, A. Rimessi, J. M. Suski, M. R. Wieckowski, P. Pinton, Cell Calcium 2012, 52, 36. - 38S. Sharifi, J. Barar, M. S. Hejazi, N. Samadi, Adv. Pharm. Bull. 2015, 5, 351. - 39Y.-J. Lee, I.-S. Hwang, Y.-J. Lee, C.-H. Lee, S.-H. Kim, H.-S. Nam, Y.-J. Choi, S.-H. Lee, J. Korean Med. Sci. 2014, 29, 1464. - 40D. Werdenberg, R. Joshi, S. Wolffram, H. P. Merkle, P. Langguth, Biopharm. Drug Dispos. 2003, 24, 259. - 41N. Singh, L. Saha, P. Kumari, J. Singh, A. Bhatia, D. Banerjee, A. Chakrabarti, Brain Res. Bull. 2019, 144, 233. - 42V. Patel, A. Joharapurkar, S. Kshirsagar, M. Patel, H. Savsani, A. Patel, R. Ranvir, M. Jain, Medicine in Drug Discovery 2022, 16, 100142. - 43A. M. Karimi, M. Salehcheh, M. Rashno, L. Khorsandi, H. Kalantari, M. J. Khodayar, Jundishapur J. of Nat. Pharma. Prod. 2023. - 44V. Baldin, J. Lukas, M. J. Marcote, M. Pagano, G. Draetta, Genes Dev. 1993, 7, 812. - 45C. E. Caldon, E. A. Musgrove, Cell Div. 2010, 5, 2. - 46R. Loewe, T. Valero, S. Kremling, B. Pratscher, R. Kunstfeld, H. Pehamberger, P. Petzelbauer, Cancer Res. 2006, 66, 11888. - 47J.-L. Suen, Y. Chang, Y.-S. Shiu, C.-Y. Hsu, P. Sharma, C.-C. Chiu, Y.-J. Chen, T.-C. Hour, E.-M. Tsai, J. Pathol. 2019, 249, 485. - 48S. khosravi, H. Bardania, R. Mansouri, M. T. Tahoori, F. Ghafari, A. mohammadzadeh, M. H. Fouani, A. A. Pourfathollah, M. Soleimani, Colloids Surf. B. Biointerfaces 2021, 208, 112091. - 49B. Tastan, B. I. Arioz, K. U. Tufekci, E. Tarakcioglu, C. P. Gonul, K. Genc, S. Genc, Front. Immunol. 2021, 12, 737065. - 50Y. J. Liu, L. Shi, W. Qiu, Y. Shi, Mol. Cell. Toxicol. 2022, 18, 509. - 51I. Kastrati, M. I. Siklos, E. L. Calderon-Gierszal, L. El-Shennawy, G. Georgieva, E. N. Thayer, G. R. J. Thatcher, J. Frasor, J. Biol. Chem. 2016, 291, 3639. - 52G. O. Gillard, B. Collette, J. Anderson, J. Chao, R. H. Scannevin, D. J. Huss, J. D. Fontenot, J. Neuroimmunol. 2015, 283, 74. - 53Y. Liu, J. Wang, X. Zhang, Int. J. Biol. Sci. 2022, 18, 4400. - 54W. Liu, J. Zhu, J. Cheng, Q. Tand, S. Long, Mol. Cell. Toxicol. 2023. - 55L. A. Ridgley, A. E. Anderson, N. J Maney, N. Naamane, A. J. Skelton, C. A. Lawson, P. Emery, J. D. Isaacs, R. J. Carmody, A. G. Pratt, Front. immunol. 2019, 10. - 56S. Podgaec, M. S. Abrao, J. A. Dias, L. V. Rizzo, R. M. de Oliveira, E. C. Baracat, Hum. Reprod. 2007, 22, 1373. - 57K. N. Khan, S.-W. Guo, K. Ogawa, A. Fujishita, T. Mori, J. Reprod. Immunol. 2024, 163, 104242. - 58J. He, Y. Xu, M. Yi, C. Gu, Y. Zhu, G. Hu, J. Int. Med. Res. 2020, 48, 030006051987140. 10.1177/0300060519871407Google Scholar - 59Z.-X. Huang, D.-C. Lin, H.-Y. Zhang, M.-J. Yang, J.-H. Chen, X.-Y. Ding, S.-J. Dai, Y.-H. Hong, G.-S. Liang, Q.-Y. Li, Q.-H. Chen, Immunology 2024, 172, 469. - 60E. A. Mills, M. A. Ogrodnik, A. Plave, Y. Mao-Draayer, Front. Neurol. 2018, 9, 5. - 61A. D. R. Lima, B. B. Ferrari, F. Pradella, R. M. Carvalho, S. L. S. Rivero, R. P. S. Quintiliano, M. A. Souza, N. L. S. Brunetti, A. M. Marques, I. P. Santos, A. S. Farias, E. C. Oliveira, L. M. B. Santos, Front. Immunol. 2024, 15, 1391949. - 62G. Montes Diaz, J. Fraussen, B. Van Wijmeersch, R. Hupperts, V. Somers, Sci. Rep. 2018, 8, 8194. - 63J. Schlöder, C. Berges, F. Luessi, H. Jonuleit, Int. J. Mol. Sci. 2017, 18, 271. - 64K. E. Pelch, K. L. Sharpe-Timms, S. C. Nagel, J. Vis. Exp. 2012, 59, e3396. - 65S. Park, W. Lim, F. W. Bazer, K.-Y. Whang, G. Song, J. Nutr. Biochem. 2019, 63, 87. Article Metrics Total unique accesses to an article’s full text in HTML or PDF/ePDF format.More metric information Scite metrics Explore this article's citation statements on scite.ai Share QR Code Generating QR code QR code copied to clipboard! Something went wrong while generating your QR code. Please try again in a moment. If the issue persists, refresh the page or contact support. Export citation Unable to load citation data. Please try again in a moment. How to cite Elkins, L. J., & Spiegelman, M. (2021). pyUserCalc: A revised Jupyter notebook calculator for uranium-series disequilibria in basalts. Earth and Space Science, 8, e2020EA001619. https://doi.org/10.1029/2020EA001619 Download Citation If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download. This feature enables you to download the bibliographic information (also called citation data, header data, or metadata) for the articles on our site. Citation manager file format Use the dropdown list to choose how to format the bibliographic data you're harvesting. Several citation manager formats are available, including EndNote and BibTex. You can then copy the formatted citation (as displayed) or download it as file, to your device. If the RefWorks format is chosen, the 'Download' button will be replaced with an option to directly export to RefWorks

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (61)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-07-29T07:08:50.896093+00:00
License: CC0 · commercial use OK